B cells are white blood cells that produce antibodies, the proteins your immune system uses to neutralize bacteria, viruses, and other threats. They are one of two main types of lymphocytes (the other being T cells) and form the backbone of what immunologists call “humoral immunity,” the branch of your immune system that works through antibodies circulating in your blood and body fluids. Every B cell is equipped to recognize one specific target, and your body contains billions of them, each tuned to a different potential invader.
Where B Cells Come From
B cells are born and raised in your bone marrow. They develop from the same stem cells that give rise to all blood cells, but they follow a unique path of maturation that takes them through several stages before they’re ready to patrol the body.
The earliest stage is the pro-B cell, where the cell begins assembling the genetic instructions for its future antibody. This is when the heavy chain of the antibody molecule gets pieced together through a process of gene rearrangement. If that assembly succeeds, the cell advances to the pre-B cell stage, where it divides several times and begins building the lighter half of its antibody. Once both halves are complete and a full antibody molecule sits on the cell’s surface, the cell is considered an immature B cell. It then leaves the bone marrow and enters the bloodstream, ready to encounter its matching target. This production line runs continuously throughout your life.
How B Cells Fight Infection
A B cell’s primary job is straightforward: find a threat, then flood the body with antibodies designed to neutralize it. But activation isn’t instant. When a B cell’s surface receptor locks onto a matching molecule from a pathogen, the B cell typically needs a second confirmation signal from a helper T cell before it fully commits. This two-key system prevents B cells from launching attacks against harmless substances.
Once activated, the B cell begins dividing rapidly and transforms into what’s called a plasma cell. Plasma cells are antibody factories. A single plasma cell pumps out roughly 2,000 antibody molecules per second. These antibodies circulate through the blood and tissues, binding to the pathogen and marking it for destruction by other immune cells, or directly blocking the pathogen from infecting your cells.
Not every threat requires T cell help, though. Some targets, particularly repetitive sugar structures on bacterial surfaces, can activate B cells directly. These “T-independent” responses tend to be faster but produce simpler, shorter-lived antibody protection.
Memory B Cells and Lasting Immunity
Not all activated B cells become plasma cells. Some become memory B cells, long-lived sentinels that remain in your body for years or even decades after an infection clears. Memory B cells don’t actively produce antibodies. They sit quietly, requiring no ongoing stimulation to survive, waiting for a second encounter with the same pathogen.
The difference between a first infection and a second one is dramatic. During a first exposure, antibodies don’t appear in your blood for about five to seven days, and the response is relatively modest. During a second exposure, memory B cells reactivate within one to two days, producing antibodies that are both more abundant and better at binding the target. This faster, stronger secondary response is the principle behind vaccination: your immune system gets a practice run so memory B cells are already in place when the real threat arrives.
The Three Main B Cell Subtypes
B cells aren’t a single uniform population. Your body maintains several specialized subtypes, each positioned to handle different kinds of threats.
- Follicular B cells are the most abundant type and the main players in long-term immune responses. They live in lymph nodes and the spleen, where they interact with T cells to mount carefully targeted responses against protein-based threats like viruses. These are the B cells that generate high-quality memory cells and long-lived plasma cells that can migrate to the bone marrow and keep producing antibodies for years.
- Marginal zone B cells sit at the edges of the spleen, positioned to intercept pathogens circulating in the blood. They respond quickly, often without T cell help, and are especially important for fighting bacteria with sugar-coated surfaces. They’re better equipped to present captured threats to other immune cells than follicular B cells are.
- B-1 cells are considered part of the innate-like immune system. They produce a steady background level of antibodies, particularly in the gut and other mucosal surfaces, providing a first line of defense before the rest of the immune system mobilizes. They’re especially effective against common bacterial components and can generate protective antibodies without needing T cell assistance.
B Cells vs. T Cells
B cells and T cells are partners, but they operate very differently. The core distinction is in how they recognize threats. B cells can directly detect whole molecules floating freely in the body, whether on the surface of a bacterium, dissolved in blood, or stuck to a toxin. Their surface receptors grab onto the three-dimensional shape of these molecules like a lock fitting a key.
T cells can’t do this. They only recognize small fragments of proteins that have been chopped up and displayed on the surface of other cells by specialized molecules. This means T cells are better suited for detecting cells that have already been infected, while B cells handle threats still roaming free outside cells. B cells produce antibodies that work at a distance. T cells either kill compromised cells directly or coordinate the broader immune response by signaling to other immune cells, including B cells themselves.
Regulatory B Cells
A smaller subset of B cells does something unexpected: instead of ramping up immune responses, they dial them down. These regulatory B cells (Bregs) produce anti-inflammatory signaling molecules that suppress overactive immune reactions and help restore balance after an infection resolves. Their best-known tool is a signaling molecule called IL-10, though researchers have since identified additional molecules they use to keep inflammation in check. Bregs are thought to play an important role in preventing autoimmune reactions, where the immune system mistakenly attacks the body’s own tissues.
When B Cells Go Wrong
Because B cells are so powerful, problems with them can be serious. When B cells mistakenly produce antibodies against the body’s own tissues, the result is autoimmune disease. Conditions like lupus, Sjögren syndrome, and type 1 diabetes all involve some degree of B cell dysfunction. In lupus, for instance, B cells generate antibodies that attack DNA and other normal cellular components, driving widespread inflammation.
B cells can also become cancerous. Non-Hodgkin lymphomas originate from B cells in 85 to 90 percent of cases. The most common subtype, diffuse large B-cell lymphoma, accounts for 25 to 45 percent of new lymphoma diagnoses each year. Autoimmune conditions themselves appear to increase this risk: people with lupus develop this type of lymphoma at two to three times the rate of the general population, and patients with Sjögren syndrome face a relative risk between two and roughly six and a half times higher.
Clinicians identify B cells using surface proteins, the most important being CD19 and CD20. These markers aren’t just diagnostic tools. They serve as targets for treatment. Several therapies for both autoimmune diseases and B-cell cancers work by homing in on CD20 to selectively deplete problematic B cells while leaving the rest of the immune system relatively intact.